BIO EUROPE 2018 CRISPR in 5 years’ time: Late-phase trials in major markets, predicts CEO 19-Nov-2018 By Flora Southey In the future, a single change in DNA could help cure cystic fibrosis, sickle cell anaemia, or haemoglobinopathies, says ERS Genomics CEO.
Thermo and Oxford Genetics expand CRISPR toolkits with ERS deals 25-Sep-2018 By Ben Hargreaves Thermo Fisher and Oxford Genetics have announced separate plans to partner with ERS Genomics, gaining access to CRISPR gene editing technology.